PMC:7532482 / 1694-2168 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T15","span":{"begin":224,"end":232},"obj":"Disease"},{"id":"T16","span":{"begin":355,"end":390},"obj":"Disease"},{"id":"T17","span":{"begin":361,"end":390},"obj":"Disease"},{"id":"T18","span":{"begin":392,"end":396},"obj":"Disease"}],"attributes":[{"id":"A15","pred":"mondo_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A16","pred":"mondo_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"}],"text":"Its transmission route is mainly through respiratory droplets, but also through contact transmission, which has the characteristics of rapid spread, strong infectivity and general susceptibility of various groups of people. COVID-19 mild patients present with fever, fatigue, dry cough and other symptoms, whereas severe patients can appear with dyspnea, acute respiratory distress syndrome (ARDS) or septic shock and other symptoms. There is no special drug at present 6,7."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T22","span":{"begin":108,"end":111},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"Its transmission route is mainly through respiratory droplets, but also through contact transmission, which has the characteristics of rapid spread, strong infectivity and general susceptibility of various groups of people. COVID-19 mild patients present with fever, fatigue, dry cough and other symptoms, whereas severe patients can appear with dyspnea, acute respiratory distress syndrome (ARDS) or septic shock and other symptoms. There is no special drug at present 6,7."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T6","span":{"begin":454,"end":458},"obj":"Chemical"}],"attributes":[{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"Its transmission route is mainly through respiratory droplets, but also through contact transmission, which has the characteristics of rapid spread, strong infectivity and general susceptibility of various groups of people. COVID-19 mild patients present with fever, fatigue, dry cough and other symptoms, whereas severe patients can appear with dyspnea, acute respiratory distress syndrome (ARDS) or septic shock and other symptoms. There is no special drug at present 6,7."}

{"project":"LitCovid-PubTator","denotations":[{"id":"54","span":{"begin":216,"end":222},"obj":"Species"},{"id":"55","span":{"begin":238,"end":246},"obj":"Species"},{"id":"56","span":{"begin":321,"end":329},"obj":"Species"},{"id":"57","span":{"begin":41,"end":52},"obj":"Species"},{"id":"58","span":{"begin":224,"end":232},"obj":"Disease"},{"id":"59","span":{"begin":260,"end":265},"obj":"Disease"},{"id":"60","span":{"begin":267,"end":274},"obj":"Disease"},{"id":"61","span":{"begin":276,"end":285},"obj":"Disease"},{"id":"62","span":{"begin":346,"end":353},"obj":"Disease"},{"id":"63","span":{"begin":355,"end":390},"obj":"Disease"},{"id":"64","span":{"begin":392,"end":396},"obj":"Disease"},{"id":"65","span":{"begin":401,"end":413},"obj":"Disease"}],"attributes":[{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"Tax:9606"},{"id":"A55","pred":"tao:has_database_id","subj":"55","obj":"Tax:9606"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"Tax:9606"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"Tax:12814"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"MESH:C000657245"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"MESH:D005334"},{"id":"A60","pred":"tao:has_database_id","subj":"60","obj":"MESH:D005221"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D003371"},{"id":"A62","pred":"tao:has_database_id","subj":"62","obj":"MESH:D004417"},{"id":"A63","pred":"tao:has_database_id","subj":"63","obj":"MESH:D012128"},{"id":"A64","pred":"tao:has_database_id","subj":"64","obj":"MESH:D012128"},{"id":"A65","pred":"tao:has_database_id","subj":"65","obj":"MESH:D012772"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Its transmission route is mainly through respiratory droplets, but also through contact transmission, which has the characteristics of rapid spread, strong infectivity and general susceptibility of various groups of people. COVID-19 mild patients present with fever, fatigue, dry cough and other symptoms, whereas severe patients can appear with dyspnea, acute respiratory distress syndrome (ARDS) or septic shock and other symptoms. There is no special drug at present 6,7."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T5","span":{"begin":260,"end":265},"obj":"Phenotype"},{"id":"T6","span":{"begin":267,"end":274},"obj":"Phenotype"},{"id":"T7","span":{"begin":276,"end":285},"obj":"Phenotype"},{"id":"T8","span":{"begin":346,"end":353},"obj":"Phenotype"},{"id":"T9","span":{"begin":361,"end":381},"obj":"Phenotype"},{"id":"T10","span":{"begin":408,"end":413},"obj":"Phenotype"}],"attributes":[{"id":"A5","pred":"hp_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0012378"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0031246"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0002094"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0002098"},{"id":"A10","pred":"hp_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/HP_0031273"}],"text":"Its transmission route is mainly through respiratory droplets, but also through contact transmission, which has the characteristics of rapid spread, strong infectivity and general susceptibility of various groups of people. COVID-19 mild patients present with fever, fatigue, dry cough and other symptoms, whereas severe patients can appear with dyspnea, acute respiratory distress syndrome (ARDS) or septic shock and other symptoms. There is no special drug at present 6,7."}

{"project":"LitCovid-sentences","denotations":[{"id":"T18","span":{"begin":0,"end":223},"obj":"Sentence"},{"id":"T19","span":{"begin":224,"end":433},"obj":"Sentence"},{"id":"T20","span":{"begin":434,"end":474},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Its transmission route is mainly through respiratory droplets, but also through contact transmission, which has the characteristics of rapid spread, strong infectivity and general susceptibility of various groups of people. COVID-19 mild patients present with fever, fatigue, dry cough and other symptoms, whereas severe patients can appear with dyspnea, acute respiratory distress syndrome (ARDS) or septic shock and other symptoms. There is no special drug at present 6,7."}